COGT

Cogent Biosciences, Inc.NASDAQHealthcare

$35.21-0.09%ClosedMarket Cap: $5.71B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-17	Wedbush	—	Outperform	—
2026-02-18	Piper Sandler	—	Overweight	—
2026-01-21	Wedbush	—	Outperform	—
2026-01-06	HC Wainwright & Co.	—	Buy	—
2025-12-19	JP Morgan	—	Overweight	—
2025-12-08	Needham	—	Hold	—
2025-11-13	HC Wainwright & Co.	—	Buy	—
2025-11-11	Baird	—	Neutral	—
2025-11-10	Leerink Partners	—	Outperform	—
2025-10-21	JP Morgan	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.64	$359.3M	8
Sun Dec 31	$1.05	$764.0M	8
Mon Dec 31	$3.07	$1.31B	6
Tue Dec 31	$4.76	$1.75B	6

COGT | Cogent Biosciences, Inc. Analyst Ratings & Price Target - InvestLog